A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated With PARP Inhibitor Resistance

Cell Reports - United States
doi 10.1016/j.celrep.2018.03.093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Quantitative Proteomics Reveals Proteins Associated With Radiotherapy Resistance in Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2008English

F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy

Molecular Cell
Cell BiologyMolecular Biology
2019English

A Genetic Interaction Map of RNA-Processing Factors Reveals Links Between Sem1/Dss1-Containing Complexes and mRNA Export and Splicing

Molecular Cell
Cell BiologyMolecular Biology
2008English

A Unique Subset of Epithelial Ovarian Cancers With Platinum Sensitivity and PARP Inhibitor Resistance

Cancer Research
Cancer ResearchOncology
2015English

RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance

Journal of Clinical Investigation
Medicine
2016English

Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2013English

Reversion and Non-Reversion Mechanisms of Resistance to PARP Inhibitor or Platinum Chemotherapy in BRCA1/2-mutant Metastatic Breast Cancer

2019English

Genetic Variants Associated With Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2013English

N6-Methylation of Adenosine (M6A) of FZD10 mRNA Contributes to PARP Inhibitor Resistance

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy